Skip to main content

Table 3 Facilitators of use of MgSO4 for fetal neuroprotection (N (%) responses for all responses that relate to facilitators)*

From: Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada

Nodes Sub-nodes Site visits (N = 128) Barriers & Facilitators Survey (N = 171)
Individual-level 17 (13.3 %) 38 (22.2 %)
 Supportive attitudes and beliefs 4 (3.1 %) 9 (5.3 %)
 Knowledge and understanding 8 (6.3 %) 15 (8.8 %)
 Early adopters/mobilizers 1 (0.8 %) 9 (5.3 %)
 Comfort/experience using MgSO4 4 (3.1 %) 5 (2.9 %)
Institutional-level 80 (62.5 %) 107 (62.6 %)
 Policies and protocols Overall 34 (26.6 %) 26 (15.2 %)
 Pre-printed orders for MgSO4 use 5 6
 Pre-mixed bags of MgSO4 8 2
 Mechanism for audit and feedback 8 3
 Unclassifiable 13 15
 Local champion/opinion leader 8 (6.3 %) 11 (6.4 %)
 Facility characteristics Overall 38 (29.7 %) 70 (40.9 %)
 Supportive institutional culture/evidence-based 18 38
 Patient load 3 10
 Human resource capacity 5 4
 Education and professional development 12 18
Social-level 31 (24.2 %) 26 (15.2 %)
 Patient voice/awareness 4 (3.1 %) 2 (1.2 %)
 Knowledge translation 17 (13.3 %) 5 (2.9 %)
 Community support 2 (1.6 %) 0
 Communication and collaboration 8 (6.3 %) 19 (11.1 %)
  1. * When the e-learning module was designed, a specific exploration of facilitators was not planned and therefore, undertaken
  2. Response about general policy/protocol and not specific to pre-printed orders, pre-printed bags, or audit/feedback
  3. Note that the total % is broken down in various ways; each area until a bolded row adds to the % listed in the bolded row